JPMorgan lowered the firm’s price target on Agilent (A) to $160 from $165 and keeps an Overweight rating on the shares. The company reported solid fiscal Q4 results while initiating fiscal 2025 guidance in-line with buy-side expectations, the analyst tells investors in a research note. The firm believes Agilent set the year off with an achievable guidance given the current geopolitical backdrop.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on A: